#ITI#Evaluation of different serologic markers for the early detection of avian influenza infection in chickens#FTI#
#IRE#Viruses of all subtypes may be introduced into domestic poultry, but only H5 and H7 low pathogenicity avian influenza viruses can mutate during circulation in poultry and emerge as high pathogenicity avian influenza variants. It is therefore essential to monitor the field situation continuously to detect low pathogenicity notifiable avian influenza (LPNAI) as soon as possible. With the emergence of the highly pathogenic H5N1, markers of infection of avian influenza are becoming more and more significant. They are important as early warning systems, and they can also be valuable tools as companion tests of vaccines (differentiating infected from vaccinated animals), but they might also be informative about the evaluation of the degree of adaptation and the timing of infection. Therefore, several experimental infections of specific-pathogen-free chickens were conducted to follow the kinetics of antibody responses against the hemagglutinin, the neuraminidase, the nucleoprotein, and the M2e after infections with LPNAI viruses isolated from waterfowl or already adapted to chicken. Overall, the immune responses against the different antigens showed similar kinetics in the different infected animals, but they were lower when the animals were infected with AI viruses originating from waterfowl, and the kinetics of the M2e antibodies was quite different. Indeed, it was rather shorter and disappeared more rapidly (approximately 35 days postinfection) compared to the kinetics of the other antibodies. Therefore, the detection of the antibodies against M2e peptide could be an interesting tool to detect recent infection, and these preliminary results indicated that the production of M2e antibodies might be correlated with the degree of adaptation of LPNAIs. Â© 2010 American Association of Avian Pathologists.#FRE#
#IPC#Avian influenza; H5 and H7 serotype; M2e; Markers of infection; Notifiable avian influenza; Serologic tests#FPC#
#IRF#Alexander D.J., An overview of the epidemiology of avian influenza, Vaccine, 25, 30, pp. 5637-5644, (2007); 
Banks J., Speidel E.S., Moore E., Plowright L., Piccirillo A., Capua I., Cordioli P., Fioretti A., Alexander D.J., Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy, Arch. Virol., 146, 5, pp. 963-973, (2001); 
Bano S., Naeem K., Malik S.A., Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens, Avian Dis, 47, 3 SUPPL., pp. 817-822, (2003); 
Black R.A., Rota P.A., Gorodkova N., Klenk H.D., Kendal A.P., Antibody response to the M2 protein of influenza A virus expressed in insect cells, J. Gen. Virol., 74, PART 1, pp. 143-146, (1993); 
Capua I., Terregino C., Cattoli G., Mutinelli F., Rodriguez J.F., Development of a DIVA (differentiating infected from vaccinated animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza, Avian Pathol, 32, 1, pp. 47-55, (2003); 
Cattoli G., Milani A., Bettini F., Serena Beato M., Mancin M., Terregino C., Capua I., Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a "dIVA" vaccination strategy for avian influenza infections in poultry, Avian Pathol, 35, 2, pp. 154-159, (2006); 
Cattoli G., Terregino C., Brasola V., Rodriguez J.F., Capua I., Development and preliminary validation of an ad hoc N1-N3 discriminatory test for the control of avian influenza in Italy, Avian Dis, 47, 3 SUPPL., pp. 1060-1062, (2003); 
Chen Y.C., Chen C.H., Wang C.H., H5 antibody detection by blocking enzyme-linked immunosorbent assay using a monoclonal antibody, Avian Dis, 52, 1, pp. 124-129, (2008); 
De Boer G.F., Back W., Osterhaus A.D., An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species, Arch. Virol., 115, 1-2, pp. 47-61, (1990); 
De Filette M., Fiers W., Martens W., Birkett A., Ramne A., Lowenadler B., Lycke N., Jou W.M., Saelens X., Improved design and intranasal delivery of an M2e-based human influenza A vaccine, Vaccine, 24, 44-46, pp. 6597-6601, (2006); 
De Filette M., Ramne A., Birkett A., Lycke N., Lowenadler B., Min Jou W., Saelens X., Fiers W., The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection, Vaccine, 24, 5, pp. 544-551, (2006); 
Dundon W.G., Maniero S., Toffan A., Capua I., Cattoli G., Appearance of serum antibodies against the avian influenza nonstructural 1 protein in experimentally infected chickens and turkeys, Avian Dis, 51, 1 SUPPL., pp. 209-212, (2007); 
Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., Heidecker G.J., Fu T.M., Joyce J., Przysiecki C.T., Keller P.M., Garsky V.M., Ionescu R., Rippeon Y., Shi L., Chastain M.A., Condra J.H., Davies M.E., Liao J., Emini E.A., Shiver J.W., Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys, Vaccine, 22, 23-24, pp. 2993-3003, (2004); 
Feng J., Zhang M., Mozdzanowska K., Zharikova D., Hoff H., Wunner W., Couch R.B., Gerhard W., Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2, Virol J, 3, (2006); 
Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., Osterhaus A.D., Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls, J. Virol., 79, 5, pp. 2814-2822, (2005); 
Gharaibeh S., Pathogenicity of an avian influenza virus serotype H9N2 in chickens, Avian Dis, 52, 1, pp. 106-110, (2008); 
Heinen P.P., De Boer-Luijtze E.A., Bianchi A.T., Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection, J. Gen. Virol., 82, PART 11, pp. 2697-2707, (2001); 
Jin M., Wang G., Zhang R., Zhao S., Li H., Tan Y., Chen H., Development of enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection of antibodies to avian influenza virus, Avian Dis, 48, 4, pp. 870-878, (2004); 
Lambrecht B., Steensels M., Van Borm S., Meulemans G., Berg Den T.Van, Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals, Avian Dis, 51, 1 SUPPL., pp. 221-226, (2007); 
Liu W., Li H., Chen Y.H., N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication, FEMS Immunol. Med. Microbiol., 35, 2, pp. 141-146, (2003); 
Marangon S., Bortolotti L., Capua I., Bettio M., Dalla Pozza M., Low-pathogenicity avian influenza (LPAI) in Italy (2000-2001): Epidemiology and control, Avian Dis, 47, 3 SUPPL., pp. 1006-1009, (2003); 
Mozdzanowska K., Feng J., Eid M., Kragol G., Cudic M., Otvos Jr. L., Gerhard W., Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2, Vaccine, 21, 19-20, pp. 2616-2626, (2003); 
Mozdzanowska K., Zharikova D., Cudic M., Otvos L., Gerhard W., Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse, Virol. J., 4, (2007); 
Potier M., Mameli L., Belisle M., Dallaire L., Melancon S.B., Fluorometric assay of neuraminidase with a sodium (4- methylumbelliferylalpha-D-N-acetylneuraminate) substrate, Anal. Biochem., 94, 2, pp. 287-296, (1979); 
Prabakaran M., Ho H.T., Prabhu N., Velumani S., Szyporta M., He F., Chan K.P., Chen L.M., Matsuoka Y., Donis R.O., Kwang J., Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses, PLoS ONE, 4, 2, (2009); 
Reed L.J., Muench H., A simple method for estimating fifty endpoints, Am. J. Hyg., 27, (1938); 
Sala G., Cordioli P., Moreno-Martin A., Tollis M., Brocchi E., Piccirillo A., Lavazza A., ELISA test for the detection of influenza H7 antibodies in avian sera, Avian Dis, 47, 3 SUPPL., pp. 1057-1059, (2003); 
Schotsaert M., De Filette M., Fiers W., Saelens X., Universal M2 ectodomain-based influenza A vaccines: Preclinical and clinical developments, Expert Rev. Vaccines, 8, 4, pp. 499-508, (2009); 
Shafer A.L., Katz J.B., Eernisse K.A., Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera, Avian Dis, 42, 1, pp. 28-34, (1998); 
Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., Lohman K., Daum L.T., Suarez D.L., Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes, J. Clin. Microbiol., 40, 9, pp. 3256-3260, (2002); 
Spickler A.R., Trampel D.W., Roth J.A., The onset of virus shedding and clinical signs in chickens infected with high-pathogenicity and low-pathogenicity avian influenza viruses, Avian Pathol, 37, 6, pp. 555-577, (2008); 
Starick E., Werner O., Schirrmeier H., Kollner B., Riebe R., Mundt E., Establishment of a competitive ELISA (cELISA) system for the detection of influenza A virus nucleoprotein antibodies and its application to field sera from different species, J. Vet. Med. B Infect. Dis. Vet. Public Health, 53, 8, pp. 370-375, (2006); 
Steensels M., Van Borm S., Lambrecht B., De Vriese J., Le Gros F.X., Bublot M., Berg Den T.Van, Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge, Avian Dis, 51, 1 SUPPL., pp. 325-331, (2007); 
Swayne D.E., Slemons R.D., Using mean infectious dose of high-and low-pathogenicity avian influenza viruses originating from wild duck and poultry as one measure of infectivity and adaptation to poultry, Avian Dis, 52, 3, pp. 455-460, (2008); 
Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., Hogan R.J., Wu Z., Benton K.A., Tumpey T.M., Epstein S.L., Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1, Emerg. Infect. Dis., 13, 3, pp. 426-435, (2007); 
Tumpey T.M., Alvarez R., Swayne D.E., Suarez D.L., Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus, J. Clin. Microbiol., 43, 2, pp. 676-683, (2005); 
Van Borm S., Steensels M., Ferreira H.L., Boschmans M., De Vriese J., Lambrecht B., Berg Den T.Van, A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification, Avian Dis, 51, 1 SUPPL., pp. 213-220, (2007); 
Van Den Berg T., Lambrecht B., Marche S., Steensels M., Van Borm S., Bublot M., Influenza vaccines and vaccination strategies in birds, Comp. Immunol. Microbiol. Infect. Dis., 31, 2-3, pp. 121-165, (2008); 
Watanabe S., Watanabe T., Kawaoka Y., Influenza A virus lacking M2 protein as a live attenuated vaccine, J. Virol., 83, pp. 5947-5950, (2009); 
Webster R.G., Peiris M., Chen H., Guan Y., H5N1 outbreaks and enzootic influenza, Emerg. Infect. Dis., 12, 1, pp. 3-8, (2006); 
Zhao S., Jin M., Li H., Tan Y., Wang G., Zhang R., Chen H., Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens, Avian Dis, 49, 4, pp. 488-493, (2005); 
Zhou E.M., Chan M., Heckert R.A., Riva J., Cantin M.F., Evaluation of a competitive ELISA for detection of antibodies against avian influenza virus nucleoprotein, Avian Dis, 42, 3, pp. 517-522, (1998)#FRF#
